BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 8135919)

  • 1. Megakaryocytic and erythrocytic cell lines share a common precursor cell.
    McDonald TP; Sullivan PS
    Exp Hematol; 1993 Sep; 21(10):1316-20. PubMed ID: 8135919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
    Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
    Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postirradiation thrombocytopoiesis: suppression, recovery, compensatory states, and macromegakaryocytosis.
    Ebbe S; Phalen E; Yee T
    Prog Clin Biol Res; 1986; 215():71-89. PubMed ID: 3523530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.
    Papayannopoulou T; Brice M; Farrer D; Kaushansky K
    Exp Hematol; 1996 Apr; 24(5):660-9. PubMed ID: 8605971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large, chronic doses of erythropoietin cause thrombocytopenia in mice.
    McDonald TP; Clift RE; Cottrell MB
    Blood; 1992 Jul; 80(2):352-8. PubMed ID: 1627797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
    Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
    Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoiesis, but not thrombocytopoiesis, is affected by the presence of a large amount of subcutaneously implanted bone marrow.
    Ebbe S; Maurer H
    Exp Hematol; 1994 Sep; 22(10):1011-5. PubMed ID: 8088375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryocytopoiesis in the rat: response to thrombocytopenia induced by exchange transfusion.
    Kimura H; Segal GM; Lee MY; Adamson JW
    Exp Hematol; 1985 Nov; 13(10):1048-54. PubMed ID: 4054245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
    Mintern J; Williams N; Jackson H
    Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
    Cheng L; Qasba P; Vanguri P; Thiede MA
    J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.
    Grossmann A; Lenox J; Ren HP; Humes JM; Forstrom JW; Kaushansky K; Sprugel KH
    Exp Hematol; 1996 Aug; 24(10):1238-46. PubMed ID: 8765500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
    Laterveer L; van Damme J; Willemze R; Fibbe WE
    Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
    Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
    Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages.
    LaIuppa JA; Papoutsakis ET; Miller WM
    Exp Hematol; 1998 Aug; 26(9):835-43. PubMed ID: 9694504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic role of TPO in thrombopoiesis.
    Miyazaki H
    Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.
    Kaushansky K; Lin N; Grossmann A; Humes J; Sprugel KH; Broudy VC
    Exp Hematol; 1996 Feb; 24(2):265-9. PubMed ID: 8641351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.